Meridian Bioscience, Inc. And The University Of Tennessee Research Foundation Enter Into A License Agreement For Electrokinetic Sensor Technology

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO), today announced that it has entered into a technology and commercial license agreement with the University of Tennessee Research Foundation (UTRF) for the development of an innovative new technology that has the potential to result in a low cost, point-of-care detection platform capable of detecting proteins, small molecules, bacteria and viruses in minutes.

The University of Tennessee technology is based on electrokinetic impedance sensing using microelectrode sensor chips. These chips are able to directly detect very minute levels of a specific analyte from complex biological samples. The device works by measuring the change in electrical properties of the chip without the use of labels or expensive optical instrumentation. In addition, detection occurs in a very specific area of the chip which lessens the amount of sample required and eliminates complex sample processing inherent to other diagnostic technologies, including PCR.

Help employers find you! Check out all the jobs and post your resume.

Back to news